BDX
Becton Dickinson & Company
MEDICAL INSTRUMENTS & SUPPLIES · HEALTHCARE
Becton, Dickinson and Company (BDX) is a leading American multinational medical technology company dedicated to advancing healthcare through the innovative development and manufacture of essential medical devices, instrument systems, and reagents. With a robust and diverse product portfolio that cat...
$176.54
+0.03% (+$0.06)
Volume
2.12M
52W High
$235.34
52W Low
$162.29
Market Cap
$59.84B
What to Watch This Quarter
Based on historical dataConsensus EPS
$3.33
Whisper EPS
$3.33
0.1% below consensus
Last Quarter
$2.91
Current Streak
2 Misss
Avg Surprise (4Q)
-6.45%
Next Earnings Report
Reports in 55 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Feb 9, 2026
1-Day:
+5.30%
Q4 2025
Feb 3, 2026
1-Day:
+0.66%
Q3 2025
Nov 6, 2025
1-Day:
+0.25%
5-Day:
+6.56%
Q2 2025
Aug 7, 2025
1-Day:
+3.10%
5-Day:
+3.88%
Revenue & Financial Performance
Revenue Whisper
$5.41B
TWN Proprietary Estimate
Last Quarter Revenue
$5.25B
+1.6% YoY
Gross Margin
44.6%
Net Margin: 7.3%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $5.25B | +1.6% | 44.6% | 11.3% | $382.0M |
| Q3'25 | $5.89B | +8.3% | 47.5% | 11.8% | $493.0M |
| Q2'25 | $5.51B | +10.4% | 47.8% | 16.0% | $574.0M |
| Q1'25 | $5.27B | +4.5% | 42.8% | 10.4% | $308.0M |
| Q4'24 | $5.17B | +9.8% | 43.3% | 8.8% | $303.0M |
| Q3'24 | $5.44B | +6.9% | 45.7% | 11.4% | $400.0M |
| Q2'24 | $4.99B | +2.3% | 46.2% | 12.1% | $487.0M |
| Q1'24 | $5.05B | +4.7% | 45.7% | 14.6% | $537.0M |
Company Information
Symbol
BDX
Company
Becton Dickinson & Company
Market Cap
$59.84B
Sector
HEALTHCARE
Next Earnings
Apr 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as BDX
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in MEDICAL INSTRUMENTS & SUPPLIES
Compare BDX with competitors
Side-by-side earnings comparison